about
Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lectureMetalloproteinases and tissue inhibitors of metalloproteinases.Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.Multiphoton microscopic imaging of esophagus during the early phase of tumor progression.Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions.Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cellsCathepsin B: association with plasma membrane in metastatic tumors.Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patientsBrain metastases in melanoma: roles of neurotrophins.A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.Molecular determinants of ovarian cancer plasticity.Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NFRelationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products.Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma.Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).Cytoplasmic dye transfer between metastatic tumor cells and vascular endotheliumIn vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours.Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression.17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane.Optical imaging in cancer research: basic principles, tumor detection, and therapeutic monitoring.Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.Tissue engineering concept in the research of the tumor biology.Role of fibronectin in adhesion, migration, and metastasis.Tumor markers in human biopsy material.Proteases as prognostic markers in human and canine cancers.Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products.Zinc and metalloproteinases 2 and 9: What is their relation with breast cancer?Use of antiadhesive peptide and swainsonine to inhibit metastasis.Biology of melanoma invasion and metastasis.Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotSuberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation.Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasionA systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).
P2860
Q24682862-81F547AE-0D75-4236-A7B0-11A53C3D304BQ33538435-0CE6B948-76FD-4DFC-9ED9-DC76055DDD68Q34557357-BBCB1DFF-8139-4283-9FA3-89C7B3266205Q34593810-29FBD464-0F33-4036-8B52-C5D3B88DC752Q35318370-803FB8D6-602E-4487-B13E-4C5E6004823FQ35543172-2BBD8823-0DD4-4E4E-8F34-191EFA8710E6Q35586906-6B8829C5-456C-4E0D-B149-8B0CE70FFD3EQ35599567-513632EE-49A8-45F0-B917-19D77F39ACD9Q35721214-3E7D4CD4-59CD-41D9-85C6-BEEDEBA8AF7CQ35768716-C0B3B6E1-7F5C-42DA-A6B3-91314D0A6DA7Q35823432-41A1C73F-BE36-4C40-8641-7427FC05BCB7Q35835814-018D7FB3-415B-4079-BAF9-8A4D1A6B1804Q35842085-809BF35E-810A-432B-8E1B-C3AE835FC50DQ35984781-4ED6A148-C3EA-48BF-9314-4DB5745EDBA6Q35993235-78139ECB-023E-47C3-9EA6-6677A727E4DBQ36007617-B9873BE1-CBF9-4A30-B063-9DA42DC6BEA6Q36027777-B3185BE3-524C-44BA-90A9-5B34A5FDC465Q36216532-09CF07E6-1FDB-4B00-B70F-FCA42E94C961Q36530612-8161D0A9-1CD5-4B1C-9778-DA867C7EEEEFQ36615007-71EDF891-65BD-40F7-B14A-474E7C7F7187Q36617616-EF2145EF-B338-48DF-B867-5A3A88D5291DQ36623099-75C344AD-E2F7-492F-8E28-CEEBE6B874E3Q37265640-9AEFD10B-14FF-4A7D-A276-9F5E758D3B7FQ37405432-1BFF0F48-1F56-4256-ADC6-71211D853EEFQ37901290-9AE18B3F-3114-4B4D-B105-7EA1F146CB65Q37903704-AC2DEF44-CF43-4F03-8EFE-AA7FF8A1D9A9Q38122201-5681D7A8-3865-4AF5-8D57-EAC17AF8E8F5Q38260311-047B16DC-94CF-472D-AE96-D52AB2A841F9Q38729642-8BCB1849-6E63-4917-BBBA-8E919992C177Q38823174-8D5A24FE-6820-4584-9181-F596E608229FQ38935085-079A0AAE-D208-4324-96C8-C5855567D22FQ39039558-C86738DC-FBD3-44D5-A7E0-3BDF914FF61FQ39146647-A2823F3A-20AC-43B1-B4B2-42C15A87AB81Q39609912-96399C69-5208-4908-BF9C-707AC194FD6BQ39705774-9DCEBBF7-8090-43EF-AEC5-B50C646F4A1EQ39923135-AB686528-492F-4013-A795-0ED98C3B0A80Q40290173-E4FE1265-5048-4820-B32C-646B8CF6319BQ40336251-F456E857-3679-4E88-A4D7-5EA99F37586DQ40458353-9A84A671-085A-4421-868B-30349602831EQ41140320-F763CB7A-8429-419C-BD8D-8F173FDF95D6
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Role of collagenases in tumor cell invasion.
@en
type
label
Role of collagenases in tumor cell invasion.
@en
prefLabel
Role of collagenases in tumor cell invasion.
@en
P2093
P2860
P356
P1476
Role of collagenases in tumor cell invasion.
@en
P2093
L A Liotta
U P Thorgeirsson
P2860
P2888
P304
P356
10.1007/BF00124213
P577
1982-01-01T00:00:00Z
P6179
1049772969